Navin R Pinto

19PUBLICATIONS
139CO-AUTHORS
Molecular targetsInformation systems development methodologies and practiceRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Jan 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studies.

Wenjun Kang, Lorena Lazo de la Vega, Hannah Comeau

|Jun 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Jan 08, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.

Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe

|Sep 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Navin Pinto, Catherine M Albert, Mallory R Taylor

|Apr 03, 2023
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.

Kelly C Goldsmith, Julie R Park, Kimberly Kayser

Pageof 4

Frequent Collaborators

8 joint publications

Julie R Park

7 joint publications

Margaret E Macy

5 joint publications

Wenjun Huang

4 joint publications

Steven G DuBois